# COVID-19 Antibody Responses In Cystic Fibrosis

> **NCT06274840** · — · RECRUITING · sponsor: **Pilar Azevedo** · enrollment: 1000 (estimated)

## Conditions studied

- COVID-19
- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06274840
- **Lead sponsor:** Pilar Azevedo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-08
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-08-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06274840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06274840, "COVID-19 Antibody Responses In Cystic Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06274840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*